Multiple Transport Pathways for L1210 Cells: Uptake of PTT.119, a Bifunctional Alkylator with Carrier Amino Acids
- 1 January 1988
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 34 (3) , 235-247
- https://doi.org/10.1159/000238575
Abstract
Delivery of the bifunctional alkylating agent, PTT.119 [p-F-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy-HCl], into tumor cells is significantly greater compared to L-phenylalanine mustard (L-PAM) as demonstrated by the 2-fold reduction in PTT.119 dosage required to reduce the viable L1210 cell fraction by 50% (TCD50). This increased uptake and consequent cytolytic efficacy observed in Dul-becco’s phosphate buffer was more apparent in culture medium; under this physiologic condition the TCD50 concentration of PTT.119 was 5 times lower than L-PAM. PTT.119 entry into leukemia cells was examined using competition transport assays assessing the ability of the tripeptide to compete with various amino acids and nonmetabolizable substrates for carrier receptors of the L, A and ASC transport systems. A 1-min exposure to a 1- to 50-fold excess of PTT.119 prior to addition of radiolabeled substrates significantly reduced within 60 s both sodium-dependent and sodium-independent uptake of leucine, methionine, threonine and α-[1-14C]-aminoisobutyric acid (AIB), but not MeAIB. In complimentary studies, L1210 cells were protected from PTT.119 cytolysis by an 8,000-fold excess of AIB, whereas β-2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH) only abrogated tripeptide cytotoxicity by 95–97% even at BCH:PTT.119 ratios of 200,000. Leucine and methionine protection were significantly less effective; the TCD50 of leucine and methionine were 3.23 and 2.4 μM, respectively, compared to 11.41 μM for AIB and 7.96 μM for BCH. In addition, MeAIB and phenylalanine were totally unable to protect LI210 cells from PTT.l 19-induced cytolysis. The data indicate that L1210 cells actively transport PTT.119 primarily by the BCH-sensitive, AIB-sensitive, MeAIB-insensitive L carrier system. A second, BCH-insensitive, AIB-sensitive and MeAIB-insensitive carrier which is also involved in tripeptide uptake is probably the ASC system.Keywords
This publication has 25 references indexed in Scilit:
- Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro.Journal of Biological Chemistry, 1979
- Concentrative uptake of melphalan, a cancer chemotherapeutic agent which is transported by the leucine-preferring carrier systemBiochemical and Biophysical Research Communications, 1979
- AMINO-ACID CONFERRED PROTECTION AGAINST MELPHALAN - COMPARISON OF AMINO-ACIDS WHICH REDUCE MELPHALAN TOXICITY TO MURINE BONE-MARROW PRECURSOR CELLS (CFU-C) AND MURINE-L1210 LEUKEMIA-CELLS1979
- EVIDENCE FOR ACTIVE-TRANSPORT OF MELPHALAN BY 2 AMINO-ACID CARRIERS IN L5178Y LYMPHOBLASTS INVITRO1979
- Cytotoxicity as an indicator for transport mechanism. Evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cellBiochimica et Biophysica Acta (BBA) - Biomembranes, 1979
- The regulation of amino acid transport in animal cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1978
- ENHANCEMENT OF MELPHALAN THERAPY WITH GLUTAMINASE - ASPARAGINASE1978
- Amino acid-conferred protection against melphalan—Characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cellsBiochemical Pharmacology, 1978
- Neutral amino acid transport systems of tissue culture cells.Journal of Biological Chemistry, 1977
- AMINO ACID CONFERRED RESISTANCE TO MELPHALAN .1. STRUCTURE-ACTIVITY RELATIONSHIP IN CULTURED MURINE L1210 LEUKEMIA-CELLS1976